CANbridge Pharmaceuticals Inc. has announced the appointment of Ms. Zhao Wei as a non-executive director and a member of the remuneration committee, effective June 30, 2025. Additionally, changes have been made to the Nomination and Corporate Governance Committee, now comprising Dr. James Qun Xue as chairperson, Mr. James Arthur Geraghty, Mr. Peng Kuan Chan, and Dr. Lan Hu.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.